Risk prediction of fever in neutropenia in children with cancer: A step towards individually tailored supportive therapy?

Pediatric Blood and Cancer

Volumn 51, Issue 6, 2008, Pages 778-783

  Wicki, Silvia ^a   Keisker, André ^b   Aebi, Christoph ^a   Leibundgut, Kurt ^a   Hirt, Andreas ^a   Ammann, Roland A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Fever in neutropenia; Individually tailored therapy; Infection; Prophylaxis; Risk prediction

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTEREMIA; BONE MARROW METASTASIS; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CENTRAL VEIN; CHILDHOOD CANCER; COHORT ANALYSIS; COMORBIDITY; DRUG EXPOSURE; FEBRILE NEUTROPENIA; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; POISSON DISTRIBUTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SOLID TUMOR; VASCULAR ACCESS;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INFANT; INFANT, NEWBORN; MALE; MODELS, BIOLOGICAL; NEOPLASMS; NEUTROPENIA; PROGNOSIS; RISK FACTORS;

EID: 56749179561     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21726     Document Type: Article

References (30)

1. Gurney JG, Bondy ML. Epidemiology of childhood cancer. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2006. pp. 1-13.
2. Walsh TJ, Roilides E, Groll AH, et al. Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2006. pp. 1269-1329.
3. Paganini HR, Aguirre C, Puppa G, et al. A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer. Cancer 2007;109:2572-2579.
4. Kuderer NM, Dale DC, Crawford J, et al. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006;106:2258-2266.
5. Klastersky J, Paesmans M, Georgala A, et al. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. J Clin Oncol 2006;24:4129-4134.
6. Paganini H, Gómez S, Ruvinsky S, et al. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease. Cancer 2003;97:1775-1780.
7. Ammann RA, Simon A, de Bont ES. Lowrisk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care? Pediatr Blood Cancer 2005;45:244-247.
8. Wolff D, Culakova E, Poniewierski MS, et al. Predictors of chemotherapy-induced neutropenia and its complications: Results from a prospective nationwide registry. J Support Oncol 2005;3:24-25.
9. Aapro MS, Cameron DA, Pettengell R, et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 2006;42:2433-2453.
10. Lehrnbecher T, Zimmermann M, Reinhardt D, et al. Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia. Blood 2007;109:936-943.
11. Lehrnbecher T, Varwig D, Kaiser J, et al. Infectious complications in pediatric acute myeloid leukemia: Analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 2004;18:72-77.
12. Kern WV, Cometta A, De Bock R, et al. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999;341:312-318.
13. Schlapbach LJ, Aebi C, Otth M, et al. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients. Pediatr Blood Cancer 2007;49:11-16.
14. Ammann RA, Hirt A, Ridolfi Lüthy A, et al. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol 2003;41:436-443.
15. Ammann RA, Aebi C, Hirt A, et al. Fever in neutropenia in children and adolescents: Evolution over time of main characteristics in a single center, 1993-2001. Support Care Cancer 2004;12:826-832.
16. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991. 611 p.
17. Brown H, Prescott R. Applied mixed models in medicine. 2nd edition. Chichester: Wiley; 2006. 455 p.
18. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med 2006;355:2615-2617.
19. Mullen CA, Buchanan GR. Early hospital discharge of children with cancer treated for fever and neutropenia: Identification and management of the low-risk patient. J Clin Oncol 1990;8:1998-2004.
20. Castagnola E, Paola D, Giacchino R, et al. Economic aspects of empiric antibiotic therapy for febrile neutropenia in children with cancer. Support Care Cancer 1998;6:524-528.
21. Pizzo PA, Robichaud KJ, Wesley R, et al. Fever in the pediatric and young adult patient with cancer. A. prospective study of 1001 episodes. Medicine (Baltimore) 1982;61:153-165.
22. Neth OW, Bajaj-Elliott M, Turner MW, et al. Susceptibility to infection in patients with neutropenia: The role of the innate immune system. Br J Haematol 2005;129:713-722.
23. Rackoff WR, Gonin R, Robinson C, et al. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 1996;14:919-924.
24. Rackoff WR, Ge J, Sather HN, et al. Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: A report from the Children's Cancer Group. J Pediatr Hematol Oncol 1999;21:260-267.
25. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: A multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Eur J Cancer 1999;35:770-774.
26. van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev 2007;1:CD003295.
27. Timmer-Bonte JN, de Boo TM, Smit HJ, et al. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: A Dutch randomized phase III study. J Clin Oncol 2005;23:7974-7984.
28. Neth O, Hann I, Turner MW, et al. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 2001;358:614-618.
29. Schlapbach LJ, Aebi C, Otth M, et al. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J 2007;26:989-994.
30. Sung L, Nathan PC, Lange B, et al. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: A meta-analysis of randomized controlled trials. J Clin Oncol 2004;22:3350-3356.